Trinity Biotech PLC
NASDAQ:TRIB
Trinity Biotech PLC
Research & Development
Trinity Biotech PLC
Research & Development Peer Comparison
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Trinity Biotech PLC
NASDAQ:TRIB
|
Research & Development
-$4.4m
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-2%
|
|
Medtronic PLC
NYSE:MDT
|
Research & Development
-$2.7B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-6%
|
|
STERIS plc
NYSE:STE
|
Research & Development
-$103.7m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-8%
|
See Also
What is Trinity Biotech PLC's Research & Development?
Research & Development
-4.4m
USD
Based on the financial report for Dec 31, 2023, Trinity Biotech PLC's Research & Development amounts to -4.4m USD.
What is Trinity Biotech PLC's Research & Development growth rate?
Research & Development CAGR 10Y
-2%
Over the last year, the Research & Development growth was -7%. The average annual Research & Development growth rates for Trinity Biotech PLC have been 5% over the past three years , 4% over the past five years , and -2% over the past ten years .